Kyriakopoulou E, van Kampen S, Wehrens M, Han S, de Ruiter H, Monshouwer-Kloots J
iScience. 2025; 28(3):111895.
PMID: 40034852
PMC: 11872638.
DOI: 10.1016/j.isci.2025.111895.
Shaikh T, Nguyen D, Dugal J, DiCaro M, Yee B, Houshmand N
J Cardiovasc Dev Dis. 2025; 12(2).
PMID: 39997505
PMC: 11855979.
DOI: 10.3390/jcdd12020071.
Guo S, Zha L
Genes (Basel). 2024; 15(11).
PMID: 39596569
PMC: 11593610.
DOI: 10.3390/genes15111368.
Xuan L, Guo J, Luo H, Cui S, Sun F, Wang G
iScience. 2024; 27(11):111102.
PMID: 39507261
PMC: 11539591.
DOI: 10.1016/j.isci.2024.111102.
Vouloagkas I, Agbariah A, Zegkos T, Gossios T, Tziomalos G, Parcharidou D
Heart Fail Rev. 2024; 30(1):247-256.
PMID: 39465469
DOI: 10.1007/s10741-024-10459-x.
Restoring PKP2 in arrhythmogenic cardiomyopathy.
Priori S
Nat Cardiovasc Res. 2024; 2(12):1115-1116.
PMID: 39196151
DOI: 10.1038/s44161-023-00382-z.
Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics.
Bradford W, Zhang J, Gutierrez-Lara E, Liang Y, Do A, Wang T
Nat Cardiovasc Res. 2024; 2(12):1246-1261.
PMID: 39196150
PMC: 11357983.
DOI: 10.1038/s44161-023-00370-3.
Engineered tissue geometry and Plakophilin-2 regulate electrophysiology of human iPSC-derived cardiomyocytes.
Simmons D, Malayath G, Schuftan D, Guo J, Oguntuyo K, Ramahdita G
APL Bioeng. 2024; 8(1):016118.
PMID: 38476404
PMC: 10932571.
DOI: 10.1063/5.0160677.
Arrhythmogenic Right Ventricular Cardiomyopathy Post-Mortem Assessment: A Systematic Review.
Cianci V, Forzese E, Sapienza D, Cianci A, Ieni A, Germana A
Int J Mol Sci. 2024; 25(5).
PMID: 38473714
PMC: 10931616.
DOI: 10.3390/ijms25052467.
Determinants of electrical propagation and propagation block in Arrhythmogenic Cardiomyopathy.
Jin Q, Lee K, Selimi Z, Shimura D, Wang E, Zimmerman J
J Mol Cell Cardiol. 2023; 186:71-80.
PMID: 37956903
PMC: 10872523.
DOI: 10.1016/j.yjmcc.2023.11.003.
Predicting ventricular tachycardia circuits in patients with arrhythmogenic right ventricular cardiomyopathy using genotype-specific heart digital twins.
Zhang Y, Zhang K, Prakosa A, James C, Zimmerman S, Carrick R
Elife. 2023; 12.
PMID: 37851708
PMC: 10584370.
DOI: 10.7554/eLife.88865.
Chronic diastolic stretch unmasks conduction defects in an in vitro model of arrhythmogenic cardiomyopathy.
Ng R, Gokhan I, Stankey P, Akar F, Campbell S
Am J Physiol Heart Circ Physiol. 2023; .
PMID: 37830983
PMC: 10977872.
DOI: 10.1152/ajpheart.00709.2022.
Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype-phenotype Correlation and Pathophysiology.
Fan X, Yang G, Duru F, Grilli M, Akin I, Zhou X
Stem Cell Rev Rep. 2023; 19(8):2683-2708.
PMID: 37731079
PMC: 10661732.
DOI: 10.1007/s12015-023-10615-0.
Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutation.
Wauchop M, Rafatian N, Zhao Y, Chen W, Gagliardi M, Masse S
Biomaterials. 2023; 301:122255.
PMID: 37651922
PMC: 10942743.
DOI: 10.1016/j.biomaterials.2023.122255.
Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
Kim S, Trembley M, Lee K, Choi S, MacQueen L, Zimmerman J
Stem Cell Reports. 2023; 18(9):1811-1826.
PMID: 37595583
PMC: 10545490.
DOI: 10.1016/j.stemcr.2023.07.005.
Body surface potential mapping detects early disease onset in plakophilin-2-pathogenic variant carriers.
Kloosterman M, Boonstra M, Roudijk R, Bourfiss M, van der Schaaf I, Velthuis B
Europace. 2023; 25(7).
PMID: 37433034
PMC: 10368448.
DOI: 10.1093/europace/euad197.
Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells.
Reisqs J, Moreau A, Sleiman Y, Boutjdir M, Richard S, Chevalier P
Front Physiol. 2023; 14:1191965.
PMID: 37250123
PMC: 10210147.
DOI: 10.3389/fphys.2023.1191965.
Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
Miles C, Boukens B, Scrocco C, Wilde A, Nademanee K, Haissaguerre M
Circulation. 2023; 147(21):1622-1633.
PMID: 37216437
PMC: 11073566.
DOI: 10.1161/CIRCULATIONAHA.122.061924.
Cheek-Pro-Heart: What Can the Buccal Mucosa Do for Arrhythmogenic Cardiomyopathy?.
Bueno-Beti C, Asimaki A
Biomedicines. 2023; 11(4).
PMID: 37189825
PMC: 10136099.
DOI: 10.3390/biomedicines11041207.
Microtubule plus-end tracking proteins: novel modulators of cardiac sodium channels and arrhythmogenesis.
Marchal G, Galjart N, Portero V, Remme C
Cardiovasc Res. 2023; 119(7):1461-1479.
PMID: 37040608
PMC: 10318397.
DOI: 10.1093/cvr/cvad052.